La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !
Repligen Gestione
Gestione criteri di controllo 3/4
Repligen's Il CEO è Tony Hunt, nominato in May2015, e ha un mandato di 9.25 anni. la retribuzione annua totale è $ 7.93M, composta da 11.1% di stipendio e 88.9% di bonus, comprese azioni e opzioni aziendali. possiede direttamente 0.23% delle azioni della società, per un valore di $ 18.78M. La durata media del mandato del team dirigenziale e del consiglio di amministrazione è rispettivamente 4.1 anni e 8.4 anni.
Informazioni chiave
Tony Hunt
Amministratore delegato
US$7.9m
Compenso totale
| Percentuale dello stipendio del CEO | 11.1% |
| Mandato del CEO | 9.3yrs |
| Proprietà del CEO | 0.2% |
| Durata media del management | 4.1yrs |
| Durata media del Consiglio di amministrazione | 8.4yrs |
Aggiornamenti recenti sulla gestione
Recent updates
Repligen Corporation (NASDAQ:RGEN) Stocks Shoot Up 27% But Its P/S Still Looks Reasonable
Jul 31
We Think Repligen (NASDAQ:RGEN) Can Stay On Top Of Its Debt
Jul 15Repligen: Strong Filtration Growth, Offset By Other Challenges
Jul 13Why We're Not Concerned Yet About Repligen Corporation's (NASDAQ:RGEN) 27% Share Price Plunge
Jun 14Is Now The Time To Look At Buying Repligen Corporation (NASDAQ:RGEN)?
Jun 10Repligen Stock: Still Quite Overvalued
May 30Repligen Corporation Just Missed Earnings - But Analysts Have Updated Their Models
May 03Estimating The Intrinsic Value Of Repligen Corporation (NASDAQ:RGEN)
Apr 30Repligen (NASDAQ:RGEN) Has A Pretty Healthy Balance Sheet
Apr 15At US$206, Is Repligen Corporation (NASDAQ:RGEN) Worth Looking At Closely?
Feb 13Estimating The Intrinsic Value Of Repligen Corporation (NASDAQ:RGEN)
Jan 08Why We're Not Concerned About Repligen Corporation's (NASDAQ:RGEN) Share Price
Dec 19What Does Repligen Corporation's (NASDAQ:RGEN) Share Price Indicate?
Nov 01Is Repligen (NASDAQ:RGEN) Using Too Much Debt?
Oct 17Is There An Opportunity With Repligen Corporation's (NASDAQ:RGEN) 22% Undervaluation?
Sep 29Things Look Grim For Repligen Corporation (NASDAQ:RGEN) After Today's Downgrade
Aug 09Does Repligen (NASDAQ:RGEN) Have A Healthy Balance Sheet?
Jul 17Is There Now An Opportunity In Repligen Corporation (NASDAQ:RGEN)?
Jul 03With EPS Growth And More, Repligen (NASDAQ:RGEN) Makes An Interesting Case
Jun 19Calculating The Fair Value Of Repligen Corporation (NASDAQ:RGEN)
May 23Repligen (NASDAQ:RGEN) Seems To Use Debt Quite Sensibly
Apr 11Is Now An Opportune Moment To Examine Repligen Corporation (NASDAQ:RGEN)?
Mar 28We Ran A Stock Scan For Earnings Growth And Repligen (NASDAQ:RGEN) Passed With Ease
Mar 08Estimating The Intrinsic Value Of Repligen Corporation (NASDAQ:RGEN)
Feb 20Analisi delle retribuzioni degli amministratori delegati
| Data | Compenso totale | Stipendio | Guadagni aziendali |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | -US$2m |
| Mar 31 2024 | n/a | n/a | US$15m |
| Dec 31 2023 | US$8m | US$880k | US$42m |
| Sep 30 2023 | n/a | n/a | US$116m |
| Jun 30 2023 | n/a | n/a | US$138m |
| Mar 31 2023 | n/a | n/a | US$168m |
| Dec 31 2022 | US$8m | US$800k | US$186m |
| Sep 30 2022 | n/a | n/a | US$166m |
| Jun 30 2022 | n/a | n/a | US$159m |
| Mar 31 2022 | n/a | n/a | US$146m |
| Dec 31 2021 | US$8m | US$761k | US$128m |
| Sep 30 2021 | n/a | n/a | US$119m |
| Jun 30 2021 | n/a | n/a | US$100m |
| Mar 31 2021 | n/a | n/a | US$80m |
| Dec 31 2020 | US$5m | US$725k | US$60m |
| Sep 30 2020 | n/a | n/a | US$44m |
| Jun 30 2020 | n/a | n/a | US$31m |
| Mar 31 2020 | n/a | n/a | US$23m |
| Dec 31 2019 | US$4m | US$685k | US$21m |
| Sep 30 2019 | n/a | n/a | US$23m |
| Jun 30 2019 | n/a | n/a | US$27m |
| Mar 31 2019 | n/a | n/a | US$21m |
| Dec 31 2018 | US$14m | US$600k | US$17m |
| Sep 30 2018 | n/a | n/a | US$23m |
| Jun 30 2018 | n/a | n/a | US$23m |
| Mar 31 2018 | n/a | n/a | US$29m |
| Dec 31 2017 | US$3m | US$550k | US$28m |
Compensazione vs Mercato: La retribuzione totale di Tony ($USD 7.93M ) è circa la media per le aziende di dimensioni simili nel mercato US ($USD 8.39M ).
Compensazione vs guadagni: La retribuzione di Tony è aumentata nonostante l'azienda non sia redditizia.
AMMINISTRATORE DELEGATO
Tony Hunt (60 yo)
9.3yrs
Mandato
US$7,929,275
Compensazione
Mr. Anthony J. Hunt, also known as Tony, serves as Director at 908 Devices Inc. since March 2, 2022. He has been the Chief Executive Officer of Repligen Corporation since May 21, 2015 and served as its Pre...
Gruppo dirigente
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| CEO & Director | 9.3yrs | US$7.93m | 0.23% $ 19.1m | |
| President & Chief Commercial Officer | less than a year | US$5.45m | Nessun dato | |
| CFO & Chief Compliance Officer | less than a year | US$2.03m | Nessun dato | |
| Chief Operating Officer | 4.4yrs | US$3.74m | 0.0075% $ 632.8k | |
| Senior Vice President of Filtration & Chromatography | 4.1yrs | US$1.66m | 0.049% $ 4.1m | |
| Senior Vice President of Research & Development | 7.8yrs | US$1.66m | 0.010% $ 863.4k | |
| Chief Information Officer | no data | Nessun dato | Nessun dato | |
| Global Head of Investor Relations | no data | Nessun dato | Nessun dato | |
| General Counsel & Global Head of Legal | no data | Nessun dato | Nessun dato | |
| VP & Global Head of Sales | 1.8yrs | Nessun dato | Nessun dato | |
| Vice President of Human Resources | 1.6yrs | Nessun dato | Nessun dato | |
| Senior VP of Strategy and Business Development & Global Head of Bioprocess Analytics | 4.6yrs | Nessun dato | Nessun dato |
4.1yrs
Durata media
58yo
Età media
Gestione esperta: Il team dirigenziale di RGEN è considerato esperto (durata media dell'incarico 4.1 anni).
Membri del Consiglio di amministrazione
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| CEO & Director | 9.3yrs | US$7.93m | 0.23% $ 19.1m | |
| Independent Director | 8.8yrs | US$322.84k | 0.022% $ 1.9m | |
| Member of Scientific Advisory Board | 8.4yrs | Nessun dato | Nessun dato | |
| Independent Director | 1.5yrs | US$453.50k | 0.0070% $ 589.1k | |
| Independent Chairperson of the Board | 18.9yrs | US$431.12k | 0.16% $ 13.1m | |
| Independent Director | 4.2yrs | US$287.84k | 0.0050% $ 419.9k | |
| Member of Scientific Advisory Board | 8.4yrs | Nessun dato | Nessun dato | |
| Member of Scientific Advisory Board & Independent Director | 8.4yrs | US$282.84k | 0.00095% $ 79.9k | |
| Member of Scientific Advisory Board | 8.4yrs | Nessun dato | Nessun dato | |
| Independent Director | 4.4yrs | US$287.84k | 0.0042% $ 352.6k | |
| Member of Scientific Advisory Board | no data | Nessun dato | Nessun dato | |
| Independent Director | 10.2yrs | US$307.84k | 0.0071% $ 595.8k |
8.4yrs
Durata media
64yo
Età media
Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di RGEN sono considerati esperti (durata media dell'incarico 8.4 anni).